Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3860941 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL28700362 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7980679 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3858716 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2553409 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2556958 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8570324 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL28421658 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3858039 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3321796 | 0.98 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11859034-B2 | Curable composition, method of preparing curable composition, cured material of curable composition, method of preparing cured material, and electronic device including cured material | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| US-20230345749-A1 | QUANTUM DOT, METHOD OF PREPARING THE SAME, AND INK COMPOSITION, LIGHT-EMITTING DEVICE, OPTICAL MEMBER, AND APPARATUS INCLUDING THE QUANTUM DOT | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-26 | — | — | US | disclosed |
| US-11649401-B2 | Quantum dot-containing material, method of preparing the same, and optical member and apparatus including the quantum dot-containing material | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-16 | — | — | US | disclosed |
| US-20230086283-A1 | CURABLE COMPOSITION, METHOD OF PREPARING CURABLE COMPOSITION, CURED MATERIAL OF CURABLE COMPOSITION, METHOD OF PREPARING CURED MATERIAL, AND ELECTRONIC DEVICE INCLUDING CURED MATERIAL | SAMSUNG DISPLAY CO LTD (KR) | 2023-03-23 | — | — | US | disclosed |
| US-11512159-B2 | Curable composition, method of preparing curable composition, cured material of curable composition, method of preparing cured material, and electronic device including cured material | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-11-29 | — | — | US | disclosed |
| EP-3763801-B1 | QUANTUM DOT-CONTAINING MATERIAL, METHOD OF PREPARING THE SAME, AND OPTICAL MEMBER AND APPAPRATUS INCLUDING THE QUANTUM DOT-CONTAINING MATERIAL | SAMSUNG DISPLAY CO LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| US-20210198401-A1 | CURABLE COMPOSITION, METHOD OF PREPARING CURABLE COMPOSITION, CURED MATERIAL OF CURABLE COMPOSITION, METHOD OF PREPARING CURED MATERIAL, AND ELECTRONIC DEVICE INCLUDING CURED MATERIAL | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-07-01 | — | — | US | disclosed |
| US-20210009893-A1 | QUANTUM DOT-CONTAINING MATERIAL, METHOD OF PREPARING THE SAME, AND OPTICAL MEMBER AND APPARATUS INCLUDING THE QUANTUM DOT-CONTAINING MATERIAL | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
| EP-3763801-A1 | QUANTUM DOT-CONTAINING MATERIAL, METHOD OF PREPARING THE SAME, AND OPTICAL MEMBER AND APPAPRATUS INCLUDING THE QUANTUM DOT-CONTAINING MATERIAL | Samsung Display Co., Ltd. (KR) | 2021-01-13 | — | — | EP | disclosed |
| US-20070027335-A1 | Method for producing purified 2-cyanoacrylate | TOAGOSEI CO., LTD. | 2007-02-01 | — | — | US | disclosed |
| EP-1632478-A1 | METHOD FOR PRODUCING PURIFIED 2-CYANOACRYLATE | TOAGOSEI CO., LTD. (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-6716943-B2 | COPOLYMER OF SEVERAL ETHYLENIC UNSATURATED MONOMERS CONTAINING A FLUORINATED ALKYL GROUP, A SILICONE CHAIN, AND A POLYOXYALKYLENE GROUP; SURFACE LOSS ENERGY OF IS < 110 X 10-5 MJ IN AN ORGANIC SOLVENT | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2004-04-06 | — | — | US | disclosed |
| US-6635632-B1 | Alzheimer's disease | ATHENA NEUROSCIENCES, INC. | 2003-10-21 | — | — | US | disclosed |
| US-20020103316-A1 | Surface active agent containing fluorine and coating compositions using the same | DAINIPPON INK. AND CHEMICALS, INC. (JP) | 2002-08-01 | — | — | US | disclosed |
| US-6384168-B1 | COPOLYMER OF FLUORINATED ALKYL ACRYLATES AND SHORT CHAIN SILICONE (METH)ACRYLATES; REDUCED SURFACE LOSS ENERGY; LEVELING | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-05-07 | — | — | US | disclosed |
| US-6313244-B1 | USED IN COATING PAINTS OR LAMINATES WITH UNIFORMITY AND SURFACE SMOOTHNESS BY A SPRAY COATING, AND IN FIELD OF COATING THIN COAT OF PHOTO-RESIST CONTAINING A PHOTO-SENSITIZER BY A SPIN-COATING FOR THE PRODUCTION OF | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2001-11-06 | — | — | US | disclosed |
| US-6156860-A | Surface active agent containing fluorine and coating compositions using the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2000-12-05 | — | — | US | disclosed |
| US-4189606-A | ABOSTIFACIENT | GRUPPO LEPETIT S.P.A. (IT) | 1980-02-19 | — | — | US | disclosed |
| US-4182903-A | ABOSTIFACIENTS | GRUPPO LEPETIT S.P.A. (IT) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11859034-B2 | Curable composition, method of preparing curable composition, cured material of curable composition, method of preparing cured material, and electronic device including cured material | SEM1, ASH2L, CBLC | GPR84 4446/4885FFAR1 3549/4885MAPT 1265/4885 |
| US-11512159-B2 | Curable composition, method of preparing curable composition, cured material of curable composition, method of preparing cured material, and electronic device including cured material | SEM1, ASH2L, CBLC | GPR84 4446/4885FFAR1 3549/4885MAPT 1265/4885 |
| US-20210198401-A1 | CURABLE COMPOSITION, METHOD OF PREPARING CURABLE COMPOSITION, CURED MATERIAL OF CURABLE COMPOSITION, METHOD OF PREPARING CURED MATERIAL, AND ELECTRONIC DEVICE INCLUDING CURED MATERIAL | SEM1, ASH2L, CBLC | GPR84 4446/4885FFAR1 3549/4885MAPT 1265/4885 |
| US-20230086283-A1 | CURABLE COMPOSITION, METHOD OF PREPARING CURABLE COMPOSITION, CURED MATERIAL OF CURABLE COMPOSITION, METHOD OF PREPARING CURED MATERIAL, AND ELECTRONIC DEVICE INCLUDING CURED MATERIAL | SEM1, ASH2L, CBLC | GPR84 4446/4885FFAR1 3549/4885MAPT 1265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.